Spending growth for simple medications used to treat common health problems is outstripping spending growth for pricey ...

In this article, we are going to take a look at where Global Partners LP (NYSE:GLP) stands against other best pipeline and MLP stocks to invest in according to analysts. The global pipeline market ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

The newest generation of GLP-1 drugs has delivered life-changing benefits to patients managing diabetes, obesity, heart ...

Here is Danone North America’s commercial masterstroke laid bare: the food, beverage and nutrition company manages to promote ...

Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce inflammation and improve heart health. With such advantages, the demand ...

Preoperative use of GLP-1RAs was not associated with a significantly increased risk for postoperative aspiration pneumonia or acute respiratory failure. Preoperative use of glucagon-like peptide-1 ...

GLP-1 RAs can reduce liver fat, fibrosis progression, and resolve MASH, offering potential benefits for liver health. MASH significantly increases healthcare costs due to comorbidities like ...

You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

The drug has been approved to help treat type-2 diabetes, but a new study shows an increase in use in people with type-1 diabetes, and it may not be safe.